Indonesia Partners with Takeda to Boost Plasma Industry and Expand Access to Life-Saving Treatments

Indonesia is taking a significant step to bolster its healthcare sector by partnering with Takeda, a global biopharmaceutical company, to strengthen its plasma industry. The collaboration aims to enhance the ecosystem for producing plasma-derived medicinal products (PODPs) and improve access to these vital treatments for Indonesian citizens.

“

The government wants to build strategic industries in the health sector and ensure the public has better access to essential and innovative treatments.

Health Minister Budi Gunadi Sadikin stated that the government's goal is to build strategic health industries and ensure better access to innovative and essential medicines. This partnership involves not only the Ministry of Health but also the Ministry of Investment and the Coordinating Ministry for Economic Affairs, signaling a coordinated national effort.

“

We hope to strengthen the national health system while preparing Indonesia for future health challenges.

Sadikin has designated Takeda as a key industry player for plasma fractionation, enabling the company to collect plasma and begin the fractionation process. This initiative is envisioned as Southeast Asia's first long-term project to establish Indonesia as a hub for plasma-related scientific development, collection technology, and biopharmaceutical manufacturing and innovation.

“

This collaboration allows our team to expand access to PODPs while supporting the development of a sustainable plasma ecosystem in Indonesia.

Ramy Riad, President of Plasma-Derived Therapies at Takeda, expressed enthusiasm for the collaboration, highlighting Takeda's commitment to expanding PODP access and supporting a sustainable plasma ecosystem in Indonesia. Takeda plans an initial investment of up to $30 million over two years to build several plasma banks. These facilities will leverage Takeda's global expertise in plasma donor management and adhere to international quality and regulatory standards. The project is expected to create new job opportunities, including for healthcare professionals and lab technicians, while fostering human resource development through training and knowledge transfer.

“

We hope our team's global experience can support Indonesia's long-term goals in improving healthcare services, creating high-skilled jobs, and strengthening the availability of life-saving and life-sustaining treatments for patients.